141 related articles for article (PubMed ID: 29035017)
21. Role of radiotherapy in the treatment of renal cell cancer: updated and critical review.
Fusco V; Parisi S; d'Andrea B; Troiano M; Clemente MA; Morelli F; Caivano R; Guglielmi G
Tumori; 2017 Nov; 103(6):504-510. PubMed ID: 28604998
[TBL] [Abstract][Full Text] [Related]
22. Trend in Stereotactic Radiation Therapy Use for Management of Bone and Brain Metastases in Patients with Renal Cell Carcinoma in Australia.
Ong WL; Siva S; Milne RL; Foroudi F; Millar JL
Oncologist; 2021 Jul; 26(7):e1288-e1289. PubMed ID: 33844360
[TBL] [Abstract][Full Text] [Related]
23. Stereotactic Ablative Body Radiotherapy: An Emerging Weapon in the Treatment Armamentarium for Renal Cell Carcinoma or a Potential Avenue for Overtreatment?
Magee DE; Wong JK; Correa AF
Eur Urol; 2022 Dec; 82(6):623-624. PubMed ID: 35945083
[No Abstract] [Full Text] [Related]
24. Endoscopic ultrasound-guided placement of fiducial markers for stereotactic body radiation therapy of pancreatic metastases from renal cell carcinoma.
Polkowski M; Pawlewicz K; Skoczylas K; Wrońska E; Lenarcik M; Reguła J
Endoscopy; 2023 Dec; 55(S 01):E876-E877. PubMed ID: 37442168
[No Abstract] [Full Text] [Related]
25. Re: Rohann J.M. Correa, Alexander V. Louie, Nicholas G. Zaorsky, et al. The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2019.06.002.
Montorsi F; Larcher A; Capitanio U
Eur Urol Focus; 2021 Mar; 7(2):406. PubMed ID: 31564640
[No Abstract] [Full Text] [Related]
26. Implementation of a volumetric modulated arc therapy treatment planning solution for kidney and adrenal stereotactic body radiation therapy.
Sonier M; Chu W; Lalani N; Erler D; Cheung P; Korol R
Med Dosim; 2016 Winter; 41(4):323-328. PubMed ID: 27745995
[TBL] [Abstract][Full Text] [Related]
27. Oligometastatic renal cell carcinoma: radiotherapy as a new standard of care?
Magné N; Latorzeff I
Lancet Oncol; 2021 Dec; 22(12):1644-1645. PubMed ID: 34856135
[No Abstract] [Full Text] [Related]
28. A planning study investigating dual-gated volumetric arc stereotactic treatment of primary renal cell carcinoma.
Devereux T; Pham D; Kron T; Foroudi F; Supple J; Siva S
Med Dosim; 2015; 40(1):82-8. PubMed ID: 25498837
[TBL] [Abstract][Full Text] [Related]
29. Technique for stereotactic body radiotherapy for spinal metastases.
Foote M; Letourneau D; Hyde D; Massicotte E; Rampersaud R; Fehlings M; Fisher C; Lewis S; Macchia NL; Yu E; Laperriere NJ; Sahgal A
J Clin Neurosci; 2011 Feb; 18(2):276-9. PubMed ID: 21147535
[TBL] [Abstract][Full Text] [Related]
30. Stereotactic body radiation therapy (SBRT): A new treatment option in renal cancer.
Couñago F; López-Campos F
Actas Urol Esp (Engl Ed); 2024 May; 48(4):260-261. PubMed ID: 37984716
[No Abstract] [Full Text] [Related]
31. Editorial Comment to Stereotactic body radiation therapy for kidney cancer. Where do we stand?
Goto Y
Int J Urol; 2023 May; 30(5):445-446. PubMed ID: 36852924
[No Abstract] [Full Text] [Related]
32. Treatment of brain metastases in renal cell carcinoma: radiotherapy, radiosurgery, or surgery?
Muacevic A; Siebels M; Tonn JC; Wowra B
World J Urol; 2005 Jul; 23(3):180-4. PubMed ID: 15791468
[TBL] [Abstract][Full Text] [Related]
33. Hypofractionated stereotactic radiotherapy and radiosurgery for the treatment of patients with radioresistant brain metastases.
Scorsetti M; Facoetti A; Navarria P; Bignardi M; De Santis M; Ninone SA; Lattuada P; Urso G; Vigorito S; Mancosu P; Del Vecchio M
Anticancer Res; 2009 Oct; 29(10):4259-63. PubMed ID: 19846983
[TBL] [Abstract][Full Text] [Related]
34. Stereotactic Radiotherapy for Renal Cell Carcinoma: The Fallacy of (False) Positive Post-treatment Biopsy?
Correa RJM; Appu S; Siva S
Eur Urol; 2023 Sep; 84(3):287-288. PubMed ID: 37032187
[No Abstract] [Full Text] [Related]
35. Adding Stereotactic Radiation to the Multidisciplinary Armamentarium for Localized Renal Cell Carcinoma: Ready for Primetime? : An Editorial Regarding a Recent 5-Year Efficacy and Safety Report of a Multicenter Cohort of Primary RCC Patients Treated with SABR.
Koehne EL; Psutka SP
Ann Surg Oncol; 2023 Nov; 30(12):6947-6949. PubMed ID: 37335349
[No Abstract] [Full Text] [Related]
36. Regression of non-irradiated metastases after extracranial stereotactic radiotherapy in metastatic renal cell carcinoma.
Wersäll PJ; Blomgren H; Pisa P; Lax I; Kälkner KM; Svedman C
Acta Oncol; 2006; 45(4):493-7. PubMed ID: 16760190
[No Abstract] [Full Text] [Related]
37. Overall survival after stereotactic radiotherapy or surgical metastasectomy in oligometastatic renal cell carcinoma patients treated at two Swedish centres 2005-2014.
Stenman M; Sinclair G; Paavola P; Wersäll P; Harmenberg U; Lindskog M
Radiother Oncol; 2018 Jun; 127(3):501-506. PubMed ID: 29754859
[TBL] [Abstract][Full Text] [Related]
38. Combined high dose radiation and pazopanib in metastatic renal cell carcinoma: a phase I dose escalation trial.
De Wolf K; Rottey S; Vermaelen K; Decaestecker K; Sundahl N; De Lobel L; Goetghebeur E; De Meerleer G; Lumen N; Fonteyne V; De Maeseneer D; Ost P
Radiat Oncol; 2017 Sep; 12(1):157. PubMed ID: 28938918
[TBL] [Abstract][Full Text] [Related]
39. Stereotactic Ablative Radiotherapy as a Tool in Renal Cell Carcinoma for Building RAPPORT with Systemic Therapy.
Mercier C; Strijbos M; Ost P
Eur Urol; 2022 Apr; 81(4):373-374. PubMed ID: 35063309
[No Abstract] [Full Text] [Related]
40. Stereotactic radiosurgery for brain metastasis from renal cell carcinoma.
Nieder C
Cancer; 1999 Jan; 85(1):251-3. PubMed ID: 9922004
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]